Date Filed | Type | Description |
10/03/2019 |
4
| Giordano Natasha (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 20,972 shares
@ $0 |
|
10/03/2019 |
4
| Rogers Steven (President) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 34,500 shares
@ $0 |
|
10/03/2019 |
4
| EILENDER ALBERT L (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 294,672 shares
@ $0 |
|
10/03/2019 |
4
| BRITTON WILLIAM N (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 50,771 shares
@ $0 |
|
10/03/2019 |
4
| Kennally William C. III (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 64,334 shares
@ $0 |
|
10/03/2019 |
4
| Yarosh Daniel B. (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 14,916 shares
@ $0 |
|
10/03/2019 |
4
| LEVIN ALAN G (Director) has filed a Form 4 on ACETO CORP
Txns:
| Disposed of 18,248 shares
@ $0 |
|
10/01/2019 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/01/2019 |
8-K
| Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or ... |
09/20/2019 |
8-K
| Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers;... |
08/26/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
08/20/2019 |
RW
| Form RW - Registration Withdrawal Request: |
08/15/2019 |
8-K
| Quarterly results |
08/02/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
07/16/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
07/02/2019 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex... |
06/18/2019 |
8-K
| Quarterly results |
06/05/2019 |
8-K/A
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
06/03/2019 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
06/03/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
05/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/03/2019 |
8-K
| Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen... |
04/30/2019 |
8-K
| Completion of Acquisition or Disposition of Assets |
04/25/2019 |
8-K
| Completion of Acquisition or Disposition of Assets |
04/22/2019 |
GN
| ACETO Completes the Sale of Rising Pharmaceuticals |
04/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/15/2019 |
GN
| ACETO to Sell its Chemicals Business Assets to New Mountain Capital |
04/15/2019 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. PORT WASHINGTON, N.Y., April 12, 2019 -- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court to sell the assets of Rising Pharmaceuticals and Rising’ s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business, on a cash-free and debt-free basis. The sale was conducted through a Court-supervised process under Section 363 of the Bankruptcy Code..." |
|
|